| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/02/2011 | CN101961380A Chinese compound preparation for treating coronary heart disease and preparation method thereof |
| 02/02/2011 | CN101961379A Near infrared spectrum identification method for red sage roots |
| 02/02/2011 | CN101961376A Method for refining sweet basil herb extract |
| 02/02/2011 | CN101961371A Method for extracting and separating ginsenoside, flavone and polysaccharide from sweet gynostemma pentaphylla |
| 02/02/2011 | CN101961363A Preparation method of active pseudo-ginseng slices |
| 02/02/2011 | CN101961362A Method for preparing active pseudo-ginseng granule |
| 02/02/2011 | CN101961361A Method for preparing active pseudo-ginseng |
| 02/02/2011 | CN101961360A Near infrared spectrum identification method for pseudo-ginseng |
| 02/02/2011 | CN101961353A Earthworm extractive, preparation method and application thereof and earthworm extractive-containing medicinal composition |
| 02/02/2011 | CN101961340A Application of pedunculoside in preparing medicine for treating coronary heart disease |
| 02/02/2011 | CN101961339A Application of 23-HBA for preparing drug to reduce cardiotoxicity caused by adriamycin |
| 02/02/2011 | CN101961324A Prescription and preparation method of etofbrate release capsules |
| 02/02/2011 | CN101961310A Preparation technology of ligustrazine hydrochloride injecting liquid |
| 02/02/2011 | CN101961309A Process for preparing pantoprazole sodium for injection |
| 02/02/2011 | CN101961192A Chinese medicinal health-care pillow |
| 02/02/2011 | CN101961191A Chinese medicinal health care pillow |
| 02/02/2011 | CN101961156A Nano AgFe2O3 antibacterial deodorization far infrared magnetic health-care shoe |
| 02/02/2011 | CN101664508B Drug combination for treating centrality serous chorioretinitis |
| 02/02/2011 | CN101642431B Ozagrel sodium liposome injection |
| 02/02/2011 | CN101601710B Application of traditional Chinese medicine composition in preparation of medicament for preventing and treating cerebral ischemia |
| 02/02/2011 | CN101596177B Coenzyme Q10 self-emulsifying composition, preparation method and application thereof |
| 02/02/2011 | CN101574456B Blood circulation and channel invigorating soup |
| 02/02/2011 | CN101491500B Meglumine adenosine cyclphosphate microspheres and production method thereof |
| 02/02/2011 | CN101468029B Difructose anhydride-containing composition and use thereof |
| 02/02/2011 | CN101407558B Preparation of Dendrobium nobile polysaccharide extract and use there |
| 02/02/2011 | CN101362803B Fusion proteins of tick anticoagulant peptide and staphylococcus aureus superantigen-like protein, preparation and application thereof |
| 02/02/2011 | CN101362765B 5,7-diaminopyrazolo '4,3-d-pyrimidines with PDE-5 inhibiting activity |
| 02/02/2011 | CN101195570B Salt amino acid of ferulic acid |
| 02/02/2011 | CN101156933B A medicine for treating cerebrovascular disease |
| 02/02/2011 | CN101143846B Metal salt of quinaprilat |
| 02/01/2011 | US7879993 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 02/01/2011 | US7879966 pH-sensitive polymer |
| 02/01/2011 | US7879878 Quinolone derivative or salt thereof |
| 02/01/2011 | US7879842 Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 02/01/2011 | US7879841 crystal structured 3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one hydrochloride, used for the treatment of angina pectoris, myocardial infarct, and congestive heart failure; bradycardial agents |
| 02/01/2011 | US7879840 Ryanodine receptors (RyRs) modulators comprising 1,4-benzothiazepine derivatives, that regulate calcium channel functioning in cells, used for the treatment of cardiovascular disorders and muscular disorders |
| 02/01/2011 | US7879831 Enhanced drug delivery in transdermal systems |
| 02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | CA2494091C Substituted furo [2,3-b| pyridine derivatives |
| 02/01/2011 | CA2484935C Amide derivatives as inhibitors of the enzymatic activity of renin |
| 02/01/2011 | CA2481055C Combinations of quinolinone derivatives and 5-fu or cpt 11 |
| 02/01/2011 | CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 02/01/2011 | CA2470971C Use of pharmaceutical composition containing epidermal growth factor (egf) for preventing diabetic limb amputation |
| 02/01/2011 | CA2467097C The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 02/01/2011 | CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 02/01/2011 | CA2453747C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use |
| 02/01/2011 | CA2453442C Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 02/01/2011 | CA2451206C Urea derivatives with antiproteolytic activity |
| 02/01/2011 | CA2446812C Novel sulfonate-substituted pyrazolopyridine derivatives |
| 02/01/2011 | CA2427375C Pharmaceutical dronedarone composition for parenteral administration |
| 02/01/2011 | CA2405508C Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 02/01/2011 | CA2388369C Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
| 02/01/2011 | CA2380857C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 01/27/2011 | WO2011011388A2 Neuregulin induced regeneraton of heart muscle muscle |
| 01/27/2011 | WO2011011232A1 Dual-acting oxazole antihypertensive agents |
| 01/27/2011 | WO2011011123A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| 01/27/2011 | WO2011011092A1 Methods and compositions to reduce oxidative stress |
| 01/27/2011 | WO2011010737A1 Guide nucleic acid for cleavage of micro-rna |
| 01/27/2011 | WO2011010706A1 Fgf21 cis-element binding substance |
| 01/27/2011 | WO2011010691A1 Polyion complex comprising phd2 expression inhibiting substance |
| 01/27/2011 | WO2011010682A1 Sterol derivative |
| 01/27/2011 | WO2011010583A1 Method for screening for oligonucleotide, and oligonucleotide library |
| 01/27/2011 | WO2011010316A1 Pharmaceutical compositions of irbesartan |
| 01/27/2011 | WO2011010080A1 Inhibitor of inflammatory conditions |
| 01/27/2011 | WO2011009943A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders |
| 01/27/2011 | WO2011009697A1 Antisense oligomers targeting pcsk9 |
| 01/27/2011 | WO2011009382A1 Use of polypeptide micromolecule mlif in preparing medicine for preventing and treating myocardial ischemia |
| 01/27/2011 | WO2010140162A3 A process for preparing stem cell based formulations |
| 01/27/2011 | WO2010138210A8 Methods of saponifying xanthophyll esters and isolating xanthophylls |
| 01/27/2011 | WO2010056630A8 Triazolopyrimidinones and methods of use thereof |
| 01/27/2011 | US20110023155 Novel dna fragment and use thereof |
| 01/27/2011 | US20110021974 Retinitis pigmentosa treatment and prophalaxis |
| 01/27/2011 | US20110021972 Composition and Device Structure For Iontophoresis |
| 01/27/2011 | US20110021772 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 01/27/2011 | US20110021766 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 01/27/2011 | US20110021633 Antagonists of the Magnesium Binding Defect as Therapeutic Agents and Methods for Treatment of Abnormal Physiological States |
| 01/27/2011 | US20110021631 Method of preparing stabilized pharmaceutical compositions comprising active ingredients susceptible to conversion to alternate polymorph forms |
| 01/27/2011 | US20110021621 Drug for treating circulatory insufficiency |
| 01/27/2011 | US20110021612 Nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/27/2011 | US20110021605 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 01/27/2011 | US20110021585 Dual-acting antihypertensive agents |
| 01/27/2011 | US20110021581 Dosing regimen for a selective s1p1 receptor agonist |
| 01/27/2011 | US20110021573 Antagonists of prostaglandin d2 receptors |
| 01/27/2011 | US20110021561 Quinoline compound and pharmaceutical composition, preparation method and uses thereof |
| 01/27/2011 | US20110021559 Aminopyridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021558 Thieno-pyridine derivatives as mek inhibitors |
| 01/27/2011 | US20110021550 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 01/27/2011 | US20110021541 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/27/2011 | US20110021540 Bis-(Sulfonylamino) Derivatives in Therapy 066 |
| 01/27/2011 | US20110021537 Heterocyclic pyrazole-carboxamidesas p2y12 antagonists |
| 01/27/2011 | US20110021532 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/27/2011 | US20110021529 P53 activating compounds |
| 01/27/2011 | US20110021527 Dual-acting oxazole antihypertensive agents |
| 01/27/2011 | US20110021526 Pharmaceutical Composition for Treatment of Diabetic Complications |
| 01/27/2011 | US20110021525 P70S6 Kinase Modulators and Method of Use |
| 01/27/2011 | US20110021521 Fused heterocyclic compounds as ion channel modulators |
| 01/27/2011 | US20110021519 Tetrahydropteridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021514 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |